Evidence map›Paper›PMID 32850475›Full record

ReviewFrontiers in cellular and infection microbiology2020

Wafa Rhimi, Bart Theelen, Teun Boekhout, Domenico Otranto, Claudia Cafarchia

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 100 citations in OpenAlex.

  1. First case of neonatal bloodstream infection caused byExperimental and therapeutic medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antifungal Susceptibility ofAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Prevalence ofOpen veterinary journal · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Effects ofInternational journal of microbiology · 2025
    Article
  18. Article
  19. Medical mycology case reports · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Wafa RhimiDipartimento di Medicina Veterinaria, Università degli Studi "Aldo Moro", Bari, Italy.
Bart TheelenYeast Research, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Teun BoekhoutYeast Research, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Domenico OtrantoDipartimento di Medicina Veterinaria, Università degli Studi "Aldo Moro", Bari, Italy.
Claudia CafarchiaDipartimento di Medicina Veterinaria, Università degli Studi "Aldo Moro", Bari, Italy.
University of Bari Aldo Moro · ITWesterdijk Fungal Biodiversity Institute · NLBu-Ali Sina University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FungemiaMalasseziaAnimalsAntifungal AgentsHumansImmunocompromised HostSkinAntifungal Agentsantifungal profilediagnosisepidemiologyfungemiaMalassezia spp.pathogenesistherapy

Identifiers

PMID32850475
PMCPMC7399178
OpenAlexW3037766364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.